Vivos (RDGL) Notes Payables (2011 - 2023)
Vivos (RDGL) reported Notes Payables of $10000.0 for Q3 2023, down 82.98% sequentially from $58761.0 in Q3 2021.
Vivos (RDGL) Notes Payables (2011 - 2023) Analysis & Trends
Vivos (RDGL) has 12 years of Notes Payables data on file, last reported at $10000.0 in Q3 2023.
- For the quarter ending Q3 2023, Notes Payables changed N/A year-over-year to $10000.0; the trailing twelve-month figure through Sep 2023 stood at $10000.0 (changed N/A YoY), and the FY2020 full-year result was $107418.0, down 54.68% from the prior year.
- Notes Payables fell to $10000.0 in Q3 2023, from $58761.0 in the prior quarter.
- In the past five years, Notes Payables ranged from a high of $237000.0 in Q4 2019 to a low of $10000.0 in Q3 2023.
- A 4-year average of $98185.0 and a median of $58534.5 in 2021 frame the typical range for Notes Payables.
- Across the five-year window, Notes Payables slumped 98.65% in 2019 and surged 1480.0% in 2021, its largest moves.
- Tracing RDGL's Notes Payables over 4 years: stood at $237000.0 in 2019, then sank by 54.68% to $107418.0 in 2020, then sank by 45.3% to $58761.0 in 2021, then tumbled by 82.98% to $10000.0 in 2023.
- Business Quant data shows RDGL's Notes Payables at $10000.0 in Q3 2023, $58761.0 in Q3 2021, and $58308.0 in Q2 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn |
| 10 | Vivos | 27.16 Mn | 25.60 Mn | -3,105.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2023 | 10,000.00 |
| Sep 30, 2021 | 58,761.00 |
| Jun 30, 2021 | 58,308.00 |
| Mar 31, 2021 | 237,000.00 |
| Dec 31, 2020 | 107,418.00 |
| Sep 30, 2020 | 32,110.00 |
| Jun 30, 2020 | 56,513.00 |
| Mar 31, 2020 | 15,000.00 |
| Dec 31, 2019 | 237,000.00 |
| Sep 30, 2019 | 187,000.00 |
| Jun 30, 2019 | 137,000.00 |
| Mar 31, 2019 | 42,110.00 |
| Dec 31, 2018 | 53,824.00 |
| Sep 30, 2018 | 383,771.00 |
| Jun 30, 2018 | 5.23 Mn |
| Mar 31, 2018 | 3.13 Mn |
| Dec 31, 2017 | 57,297.00 |
| Sep 30, 2017 | 1.96 Mn |
| Jun 30, 2017 | 1.48 Mn |
| Mar 31, 2017 | 1.07 Mn |